AURA
Price
$6.60
Change
+$0.22 (+3.45%)
Updated
Nov 28, 02:00 PM (EDT)
Capitalization
405.47M
123 days until earnings call
Intraday BUY SELL Signals
AUTL
Price
$1.41
Change
+$0.04 (+2.92%)
Updated
Nov 28, 02:00 PM (EDT)
Capitalization
363.29M
102 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

AURA vs AUTL

Header iconAURA vs AUTL Comparison
Open Charts AURA vs AUTLBanner chart's image
Aura Biosciences
Price$6.60
Change+$0.22 (+3.45%)
Volume$16.45K
Capitalization405.47M
Autolus Therapeutics
Price$1.41
Change+$0.04 (+2.92%)
Volume$14.72K
Capitalization363.29M
AURA vs AUTL Comparison Chart in %
AURA
Daily Signal:
Gain/Loss:
AUTL
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
AURA vs. AUTL commentary
Nov 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AURA is a StrongBuy and AUTL is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 28, 2025
Stock price -- (AURA: $6.38 vs. AUTL: $1.37)
Brand notoriety: AURA and AUTL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AURA: 129% vs. AUTL: 75%
Market capitalization -- AURA: $405.47M vs. AUTL: $363.29M
AURA [@Biotechnology] is valued at $405.47M. AUTL’s [@Biotechnology] market capitalization is $363.29M. The market cap for tickers in the [@Biotechnology] industry ranges from $109.65B to $0. The average market capitalization across the [@Biotechnology] industry is $2.2B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AURA’s FA Score shows that 1 FA rating(s) are green whileAUTL’s FA Score has 1 green FA rating(s).

  • AURA’s FA Score: 1 green, 4 red.
  • AUTL’s FA Score: 1 green, 4 red.
According to our system of comparison, AURA is a better buy in the long-term than AUTL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AURA’s TA Score shows that 5 TA indicator(s) are bullish while AUTL’s TA Score has 5 bullish TA indicator(s).

  • AURA’s TA Score: 5 bullish, 4 bearish.
  • AUTL’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, both AURA and AUTL are a good buy in the short-term.

Price Growth

AURA (@Biotechnology) experienced а +18.15% price change this week, while AUTL (@Biotechnology) price change was +7.87% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.81%. For the same industry, the average monthly price growth was +3.27%, and the average quarterly price growth was +75.56%.

Reported Earning Dates

AURA is expected to report earnings on Mar 31, 2026.

AUTL is expected to report earnings on Mar 10, 2026.

Industries' Descriptions

@Biotechnology (+8.81% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AURA($405M) has a higher market cap than AUTL($363M). AURA YTD gains are higher at: -22.384 vs. AUTL (-41.702). AURA has higher annual earnings (EBITDA): -107.51M vs. AUTL (-232.19M). AUTL has more cash in the bank: 454M vs. AURA (177M). AURA has less debt than AUTL: AURA (18.1M) vs AUTL (64.5M). AUTL has higher revenues than AURA: AUTL (29.9M) vs AURA (0).
AURAAUTLAURA / AUTL
Capitalization405M363M112%
EBITDA-107.51M-232.19M46%
Gain YTD-22.384-41.70254%
P/E RatioN/AN/A-
Revenue029.9M-
Total Cash177M454M39%
Total Debt18.1M64.5M28%
FUNDAMENTALS RATINGS
AUTL: Fundamental Ratings
AUTL
OUTLOOK RATING
1..100
86
VALUATION
overvalued / fair valued / undervalued
1..100
16
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
85
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AURAAUTL
RSI
ODDS (%)
Bearish Trend 3 days ago
88%
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
76%
Bullish Trend 3 days ago
79%
Momentum
ODDS (%)
Bullish Trend 3 days ago
72%
Bullish Trend 3 days ago
82%
MACD
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
76%
Bullish Trend 3 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
77%
Bearish Trend 3 days ago
86%
Advances
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 4 days ago
84%
Declines
ODDS (%)
Bearish Trend 9 days ago
84%
Bearish Trend 8 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
86%
Bullish Trend 3 days ago
84%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
AURA
Daily Signal:
Gain/Loss:
AUTL
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RAPAX11.460.11
+0.97%
Cohen & Steers Real Assets A
MKGCX32.070.28
+0.88%
BlackRock Advantage Global K
FGTAX30.210.26
+0.87%
Fidelity Advisor Mega Cap Stock A
MSCIX10.460.05
+0.48%
Madison Small Cap I
CCMMX9.18-0.04
-0.43%
Conestoga Mid Cap Investors

AUTL and

Correlation & Price change

A.I.dvisor indicates that over the last year, AUTL has been loosely correlated with OCUL. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if AUTL jumps, then OCUL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AUTL
1D Price
Change %
AUTL100%
-1.44%
OCUL - AUTL
47%
Loosely correlated
+0.08%
IMTX - AUTL
45%
Loosely correlated
-3.28%
CRSP - AUTL
45%
Loosely correlated
-0.50%
NRIX - AUTL
45%
Loosely correlated
+1.18%
AURA - AUTL
43%
Loosely correlated
+4.42%
More